Achoui M, Heyninck K, Looi CY, Mustafa AM, Haegeman G, & Mustafa MR. (2014). Immunomodulatory effects of 17-O-acetylacuminolide in RAW264.7 cells and HUVECs: Involvement of MAPK and NF-κB pathways. Dove Medical Press.
Chicago Style (17th ed.) CitationAchoui M, Heyninck K, Looi CY, Mustafa AM, Haegeman G, and Mustafa MR. Immunomodulatory Effects of 17-O-acetylacuminolide in RAW264.7 Cells and HUVECs: Involvement of MAPK and NF-κB Pathways. Dove Medical Press, 2014.
MLA (9th ed.) CitationAchoui M, et al. Immunomodulatory Effects of 17-O-acetylacuminolide in RAW264.7 Cells and HUVECs: Involvement of MAPK and NF-κB Pathways. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.